BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Monday . The company traded as high as $1.45 and last traded at $1.43, with a volume of 21542 shares trading hands. The stock had previously closed at $1.36.
BioRestorative Therapies Stock Performance
The business’s 50 day moving average price is $1.67 and its 200-day moving average price is $1.51. The firm has a market capitalization of $2.34 billion, a PE ratio of -1.27 and a beta of 102.36.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Further Reading
- Five stocks we like better than BioRestorative Therapies
- Golden Cross Stocks: Pattern, Examples and Charts
- How to Invest in Silver: A Beginner’s Guide
- Using the MarketBeat Dividend Tax Calculator
- Monday.com’s Stock Results Will Brighten Any Investor’s Week
- Business Services Stocks Investing
- 3 Must-Watch Stocks After a Bullish Goldman Sachs Recommendation
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
